BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 20, 2006
View Archived Issues
Shire makes progress in third quarter
Read More
Newly identified H5N1 influenza virus variant spreads
Read More
Phase I study reveals safety concerns with XL-999 in cancer patients
Read More
tfAAC94 safe in patients with inflammatory arthritis
Read More
Study identifies optimal alfimeprase dose for peripheral arterial occlusion
Read More
Apadenoson a potential agent for myocardial perfusion imaging
Read More
Activity of belimumab evaluated at 76 weeks in SLE patients
Read More
Studies detail potential of ruboxistaurin in diabetic cardiomyopathy
Read More
SBIR grant will support Alzheimer's diagnostic study of LymPro Test
Read More
Synairgen licenses novel peptide for treatment of asthma
Read More
GSK and NeuroSearch expand scope of strategic alliance
Read More
Improved antitumor efficacy of PEGylated SN38 derivative over SN38 and irinotecan
Read More
Intravail technology provides effective oral delivery of antisense drugs in primates
Read More
Phase III findings for Aridol to form Q2 2007 NDA filing
Read More
Bioheart expands clinical trials of MyoCell adult myogenic stem cell treatment
Read More
New phase II trial evaluates PXD-101 in MDS
Read More
Introgen licenses new nanotechnology systems
Read More
CollaGenex raises funds through sale of common stock
Read More
Enrollment completed in pivotal Tocosol Paclitaxel study
Read More
Johnson & Johnson to acquire Conor Medsystems
Read More
MN-001 begins phase III program in bronchial asthma
Read More
NorLevo begins phase I trial in Japan
Read More
European orphan drug designation for OAS-PAC-100 in ovarian cancer
Read More
Neupro recommended for approval in E.U. for advanced Parkinson's
Read More
Emerging companies showcased at BIO-Europe 2006: Palau Pharma
Read More
European CHMP recommends approval of Inovelon for Lennox-Gastaut syndrome
Read More
Lucentis recommended for approval in E.U. for wet AMD
Read More
Negative opinion handed down for Mycograb in E.U.
Read More
Exforge recommended for approval in E.U.
Read More
Recent Protemix and Dainippon Sumitomo patents describe new antidiabetic agents
Read More
New therapeutic agents for schizophrenia, anxiety, etc. disclosed in recent patents
Read More
New agents for treating neurological disorders reported in recent patents
Read More